Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-05-16 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MOULINS (03000), Allier
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE LA MADELEINE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA MADELEINE is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MOULINS (03000),
this company of category PME
shows in 2023 a net income positive of 183 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA MADELEINE (SIREN 850854522)
Indicator
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
Net income
183 357 €
308 673 €
293 522 €
138 817 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELARL PHARMACIE DE LA MADELEINE generates positive net income of 183 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2023: 139 k€ -> 183 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
183 357 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 60%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
59.925%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.238%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA MADELEINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
Debt ratio
340.365
141.639
80.591
59.925
Financial autonomy
19.224
36.447
51.157
55.238
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
59.922023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-15 pts over 3 years
In 2023, the debt ratio of SELARL PHARMACIE DE LA MA... (59.92) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
55.24%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+19 pts over 3 years
In 2023, the financial autonomy of SELARL PHARMACIE DE LA MA... (55.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 433.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
433.639
Liquidity indicators evolution SELARL PHARMACIE DE LA MADELEINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
Liquidity ratio
197.827
344.383
602.382
433.639
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
433.642023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent
In 2023, the liquidity ratio of SELARL PHARMACIE DE LA MA... (433.64) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE DE LA MADELEINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE DE LA MADELEINE is estimated at
2 163 516 €
(range 1 315 737€ - 3 041 418€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1315k€2163k€3041k€
2 163 516 €Range: 1 315 737€ - 3 041 418€
NAF 5 année 2023
Valuation method used
Net Income Multiple
183 357 €
×
11.8x
=2 163 517 €
Range: 1 315 738€ - 3 041 419€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA MADELEINE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA MADELEINE
What is the revenue of SELARL PHARMACIE DE LA MADELEINE ?
The revenue of SELARL PHARMACIE DE LA MADELEINE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DE LA MADELEINE profitable?
Yes, SELARL PHARMACIE DE LA MADELEINE generated a net profit of 183 k€ in 2023.
Where is the headquarters of SELARL PHARMACIE DE LA MADELEINE ?
The headquarters of SELARL PHARMACIE DE LA MADELEINE is located in MOULINS (03000), in the department Allier.
Where to find the tax return of SELARL PHARMACIE DE LA MADELEINE ?
The tax return of SELARL PHARMACIE DE LA MADELEINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA MADELEINE operate?
SELARL PHARMACIE DE LA MADELEINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart